247 related articles for article (PubMed ID: 27440044)
1. An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network.
Liu HC; Jamshidi N; Chen Y; Eraly SA; Cho SY; Bhatnagar V; Wu W; Bush KT; Abagyan R; Palsson BO; Nigam SK
J Biol Chem; 2016 Sep; 291(37):19474-86. PubMed ID: 27440044
[TBL] [Abstract][Full Text] [Related]
2. Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis.
Ahn SY; Jamshidi N; Mo ML; Wu W; Eraly SA; Dnyanmote A; Bush KT; Gallegos TF; Sweet DH; Palsson BØ; Nigam SK
J Biol Chem; 2011 Sep; 286(36):31522-31. PubMed ID: 21757732
[TBL] [Abstract][Full Text] [Related]
3. Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
Granados JC; Richelle A; Gutierrez JM; Zhang P; Zhang X; Bhatnagar V; Lewis NE; Nigam SK
J Biol Chem; 2021; 296():100575. PubMed ID: 33757768
[TBL] [Abstract][Full Text] [Related]
4. Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
Nigam AK; Li JG; Lall K; Shi D; Bush KT; Bhatnagar V; Abagyan R; Nigam SK
J Biol Chem; 2020 Feb; 295(7):1829-1842. PubMed ID: 31896576
[TBL] [Abstract][Full Text] [Related]
5. The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.
Bush KT; Wu W; Lun C; Nigam SK
J Biol Chem; 2017 Sep; 292(38):15789-15803. PubMed ID: 28765282
[TBL] [Abstract][Full Text] [Related]
6. A key role for the transporter OAT1 in systemic lipid metabolism.
Granados JC; Nigam AK; Bush KT; Jamshidi N; Nigam SK
J Biol Chem; 2021; 296():100603. PubMed ID: 33785360
[TBL] [Abstract][Full Text] [Related]
7. Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1).
Wikoff WR; Nagle MA; Kouznetsova VL; Tsigelny IF; Nigam SK
J Proteome Res; 2011 Jun; 10(6):2842-51. PubMed ID: 21476605
[TBL] [Abstract][Full Text] [Related]
8. Drug transporters OAT1 and OAT3 have specific effects on multiple organs and gut microbiome as revealed by contextualized metabolic network reconstructions.
Jamshidi N; Nigam SK
Sci Rep; 2022 Oct; 12(1):18308. PubMed ID: 36316339
[TBL] [Abstract][Full Text] [Related]
9. Remote effects of kidney drug transporter OAT1 on gut microbiome composition and urate homeostasis.
Ermakov VS; Granados JC; Nigam SK
JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937647
[TBL] [Abstract][Full Text] [Related]
10. Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury.
Torres AM; Dnyanmote AV; Bush KT; Wu W; Nigam SK
J Biol Chem; 2011 Jul; 286(30):26391-5. PubMed ID: 21652719
[TBL] [Abstract][Full Text] [Related]
11. Key Role for the Organic Anion Transporters, OAT1 and OAT3, in the in vivo Handling of Uremic Toxins and Solutes.
Wu W; Bush KT; Nigam SK
Sci Rep; 2017 Jul; 7(1):4939. PubMed ID: 28694431
[TBL] [Abstract][Full Text] [Related]
12. The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism.
Granados JC; Ermakov V; Maity K; Vera DR; Chang G; Nigam SK
JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36692015
[TBL] [Abstract][Full Text] [Related]
13. Conformational changes of the multispecific transporter organic anion transporter 1 (OAT1/SLC22A6) suggests a molecular mechanism for initial stages of drug and metabolite transport.
Tsigelny IF; Kovalskyy D; Kouznetsova VL; Balinskyi O; Sharikov Y; Bhatnagar V; Nigam SK
Cell Biochem Biophys; 2011 Nov; 61(2):251-9. PubMed ID: 21499753
[TBL] [Abstract][Full Text] [Related]
14. The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.
Nigam SK
Annu Rev Pharmacol Toxicol; 2018 Jan; 58():663-687. PubMed ID: 29309257
[TBL] [Abstract][Full Text] [Related]
15. Gut-derived uremic toxin handling in vivo requires OAT-mediated tubular secretion in chronic kidney disease.
Bush KT; Singh P; Nigam SK
JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271169
[TBL] [Abstract][Full Text] [Related]
16. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.
Eraly SA; Vallon V; Vaughn DA; Gangoiti JA; Richter K; Nagle M; Monte JC; Rieg T; Truong DM; Long JM; Barshop BA; Kaler G; Nigam SK
J Biol Chem; 2006 Feb; 281(8):5072-83. PubMed ID: 16354673
[TBL] [Abstract][Full Text] [Related]
17. Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.
Nigam SK; Wu W; Bush KT; Hoenig MP; Blantz RC; Bhatnagar V
Clin J Am Soc Nephrol; 2015 Nov; 10(11):2039-49. PubMed ID: 26490509
[TBL] [Abstract][Full Text] [Related]
18. Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.
Liu HC; Goldenberg A; Chen Y; Lun C; Wu W; Bush KT; Balac N; Rodriguez P; Abagyan R; Nigam SK
J Pharmacol Exp Ther; 2016 Oct; 359(1):215-29. PubMed ID: 27488918
[TBL] [Abstract][Full Text] [Related]
19. Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways.
Wu W; Jamshidi N; Eraly SA; Liu HC; Bush KT; Palsson BO; Nigam SK
Drug Metab Dispos; 2013 Oct; 41(10):1825-34. PubMed ID: 23920220
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).
Kouznetsova VL; Tsigelny IF; Nagle MA; Nigam SK
Bioorg Med Chem; 2011 Jun; 19(11):3320-40. PubMed ID: 21571536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
